Accounting reportsPreviously
|
Name | MAK-FARMA, OOO |
|---|
INN | 5026016100 |
|---|
KPP | 502701001 |
|---|
OGRN | 1115027014410 |
|---|
OKPO | 37525200 |
|---|
Address | 140083, oblast' Moskovskaya, g. Lytkarino, ul. Sportivnaya, d. D. 6, of. POMESCH. I |
|---|
|
| OKVED code | Type | Name of activity type |
|---|
| 47.73 | Core activity | Retailing drugs in specialized stores (pharmacies) | | 46.46.1 | Additional activity | Wholesale of furniture, carpets and lighting equipment | | 46.46.2 | Additional activity | Wholesale of medical and orthopedic goods, dental and laboratory supplies | | All types of activities | | 47.74 | Additional activity | Retailing products used for medical purposes, orthopedic goods in specialized stores | | 47.75 | Additional activity | Retailing of cosmetics and personal hygiene products in specialized stores |
Registration date | 16.11.2011 |
|---|
Registering department | Mezhrayonnaya inspektsiya Federal'noy nalogovoy sluzhby 17 po Moskovskoy oblasti |
|---|
|
MAK-FARMA, OOO (Moscow Oblast; INN 5026016100) was registered on 16 Nov 2011. The company's authorized capital as of July 1, 2012 was 10000 rub. Type of ownership of MAK-FARMA, OOO - Limited liability companies. Form of ownership of MAK-FARMA, OOO - Private property. Principal activities of MAK-FARMA, OOO: retailing drugs in specialized stores (pharmacies) (47.73), wholesale of furniture, carpets and lighting equipment (46.46.1), wholesale of medical and orthopedic goods, dental and laboratory supplies (46.46.2). |
Economic indicators2022
Net profit (RAS) of MAK-FARMA, OOO grew over 2022 2.40 times to 2.09 million RUB from 872.00 thousand RUB over 2021, the company informed. Revenue increased in the accounting period by 7.54% to 29.28 million RUB from 27.23 million RUB over 2021. 2021
Net profit (RAS) of MAK-FARMA, OOO dropped in 2021 2.38 times to 872.00 thousand RUB from 2.07 million RUB over the same period in 2020, the company informed. Revenue decreased in the accounting period by 5.39% to 27.23 million RUB from 28.78 million RUB in 2020. 2020
Net profit (RAS) of MAK-FARMA, OOO dropped in 2020 by 19.28% to 2.09 million RUB from 2.58 million RUB over the same period in 2019, the company informed. Revenue increased in the accounting period by 13.47% to 28.78 million RUB from 25.36 million RUB over 2019. 2019
Net profit (RAS) of MAK-FARMA, OOO grew over 2019 by 15.24% to 2.57 million RUB from 2.23 million RUB over 2018, the company informed. Revenue increased in the accounting period by 24.10% to 25.36 million RUB from 20.44 million RUB over 2018. 2018
Net profit (RAS) of MAK-FARMA, OOO dropped in 2018 by 5.71% to 2.23 million RUB from 2.37 million RUB over the same period in 2017, the company informed. Revenue increased in the accounting period by 30.12% to 20.44 million RUB from 15.71 million RUB over 2017; cost of goods sold grew by 40.63% to 17.96 million RUB from 12.77 million RUB; sales profit fell by 15.64% to 2.48 million RUB from 2.93 million RUB. 2017
Net profit (RAS) of MAK-FARMA, OOO grew over 2017 by 37.24% to 2.37 million RUB from 1.72 million RUB over 2016, the company informed. Revenue decreased in the accounting period by 19.84% to 15.71 million RUB from 19.59 million RUB in 2016; cost of goods sold decreased by 28.44% to 12.77 million RUB from 17.85 million RUB; sales profit went up 1.68 times to 2.93 million RUB from 1.75 million RUB. 2016
Net profit (RAS) of MAK-FARMA, OOO dropped in 2016 by 12.22% to 905.00 thousand RUB from 1.03 million RUB over the same period in 2015, the company informed. Revenue decreased in the accounting period by 23.29% to 14.94 million RUB from 19.48 million RUB in 2015; cost of goods sold decreased by 23.95% to 14.01 million RUB from 18.43 million RUB; sales profit fell by 11.81% to 926.00 thousand RUB from 1.05 million RUB. 2014
Net profit (RAS) of MAK-Farma, OOO dropped in 2014 2.92 times to 1.76 million RUB from 5.15 million RUB over the same period in 2013, the company informed. Revenue increased in the accounting period by 13.56% to 19.54 million RUB from 17.21 million RUB over 2013; cost of goods sold grew by 47.38% to 17.77 million RUB from 12.05 million RUB; sales profit fell 2.90 times to 1.78 million RUB from 5.16 million RUB.
unlimited access to database "Kontragent" download any information within 24 hours
Companies in the region
|